Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is BioCryst Pharmaceuticals Inc Stock Halal?
Shariah Compliance Analysis of BCRX Stock
United States Health Care Mid Cap No. As of October 2026, BioCryst Pharmaceuticals Inc (BCRX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. BioCryst Pharmaceuticals Inc does not pass Musaffa's business and financial screening criteria.
BioCryst Pharmaceuticals, Inc. is a biotechnology company. The company is headquartered in Durham, North Carolina and currently employs 435 full-time employees. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. The RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older. Its portfolio also includes navenibart, which is a late-stage, long-acting plasma kallikrein inhibitor. The company has also obtained an early-stage program for atopic dermatitis, STAR0310.
BCRX Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, BioCryst Pharmaceuticals Inc is classified as not halal.
NOT HALALBioCryst Pharmaceuticals Inc (BCRX) Chart
Fetching Price Chart...
Financial Metrics & Statements of BioCryst Pharmaceuticals Inc (BCRX)
FAQ's for BioCryst Pharmaceuticals Inc (BCRX)
- As of October 2026, BioCryst Pharmaceuticals Inc BCRX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioCryst Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in BioCryst Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of BioCryst Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of BioCryst Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of BioCryst Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for BioCryst Pharmaceuticals Inc (BCRX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
